Abstract
In 1910, Dr. P. Brooke Bland wrote, “Dysmenorrhea should never be regarded as a morbid process, but should always be looked upon as a manifestation of some systemic or local pelvic condition. It is unfortunate that many women are operated upon for dysmenorrhea without the cause first being determined” [1]. In the past, therapies used to treat dysmenorrhea have ranged from the plausible and somewhat effective, to the outlandish and useless. Everything from cauterizing the middle turbinate of the nose [2], exercise programs [3], and presacral sympathectomy [4, 5] to uterine relaxing factor [6], vasodilators [7, 8], tranquilizers [9], and hormones [10, 11] have been recommended to relieve dysmenorrhea. The use of electric current has even been advocated [12], employing an insulated chair, an intravaginal electrode, and a spark gap high-voltage generator. This treatment was to be administered for 20 min daily over a 4-week period. The treatment was reported to have had good effects, possibly do to a low return rate of patients treated in this way.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bland PB. Dysmenorrhea; its significance and treatment. J Med Soc NJ. 1910;6(12):591–4.
Mayer E. The intranasal treatment of dysmenorrhea. With a report of ninety-three cases. JAMA. 1914;62(1):6–8.
Miller NF, Berkman SJ. Dysmenorrhea. Amer. J Obstet Gynecol. 1953;65:505–16.
Cotte G. La sympathectomie hypogastrique: A-t-elle sa place dans latherapeutique gynecologique? Presse Med. 1925;33:98–102.
Black WT Jr. Use of presacral sympathectomy in the treatment of dysmenorrhea: a second look after twenty-five years. Am J Obstet Gynecol. 1964;89:16–22.
Hayden GE. Relief of primary dysmenorrhea. Obstet Gynecol. 1960;16:730–3.
Schuck F. Pain and pain relief in essential dysmenorrhea. Am J Obstet Gynecol. 1951;62(3):559–67.
Voulgaris DM. Dysmenorrhea. Treatment with Isoxsuprine. Obstet Gynecol. 1960;15:220–2.
Champlin WD, Corbit JP. Chlorpromazine and chlorpromazine combinations in the treatment of dysmenorrhea. Am J Obstet Gynecol. 1957;74(2):419–21.
Filler W. The treatment of dysmenorrhea. With special reference to the primary type. Med Clin North Am. 1951;35:861–70.
Menaker JS, Powers KD. Management of primary dysmenorrhea. Obstet Gynecol. 1962;20:66–71.
Torbett JW. The diagnosis and office treatment of some gynecologic cases. Texas State J Med. 1902;4(9):224–6.
Hulbert GT. Electricity vs. tait, or the use of electricity in inflammation as found in gynecology. St. Louis Courier of Medicine. 1888;20(3):193–217. (shown: Figures 1–2, p. 207)
Pickles VR. Prostaglandins in the human endometrium. Int J Fertil. 1967;12:335–8.
Smith RP, Powell JR. The objective evaluation of dysmenorrhea therapy. Am J Obstet Gynecol. 1980;137:314–9.
Smith RP, Powell JR. Intrauterine pressure changes during mefenamic acid treatment of primary spasmodic dysmenorrhea. Am J Obstet Gynecol. 1982;143:286–92.
Smith RP, Powell JR. Simultaneous objective and subjective evaluation of meclofenamate sodium in the treatment of primary dysmenorrhea. Am J Obstet Gynecol. 1987;157(3):611–6.
Smith RP. The dynamics of nonsteroidal anti-inflammatory therapy for primary dysmenorrhea. Obstet Gynecol. 1987;70(5):7858.
Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015;(7):CD001751.
Zahradnik HP, Hanjalic-Beck A, Groth K. Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a review. Contraception. 2010;81(3):185–96.
Dawood MY. Nonsteroidal antiinflammatory drugs and reproduction. Am J Obstet Gynecol. 1993;169:1255–65.
Zhang WY, Po ALW. Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review. Br J Obstet Gynaecol. 1998;105:780–9.
Lundström V. Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors—a promising therapeutic alternative. Acta Obstet Gynecol Scand. 1978;57(5):421–8.
Dingfelder JR. Primary dysmenorrhea treatment with prostaglandin inhibitors: a review. Am J Obstet Gynecol. 1981;140(8):874–9.
Gookin KS, Forman ES, Vecchio TJ, Wiser WL, Morrison JC. Comparative efficacy of ibuprofen, indomethacin, and placebo in the treatment of primary dysmenorrhea. South Med J. 1983;76(11):1361–2. 1367
Owen PR. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Am J Obstet Gynecol. 1984;148:96–103.
Rees MC, Cañete-Solér R, López Bernal A, Turnbull AC. Effect of fenamates on prostaglandin E receptor binding. Lancet. 1988;2(8610):541–2.
Casey FB, Appleby BJ, Buck DC. Selective inhibition of the lipoxygenase metabolic pathway of arachidonic acid by the SRA-A antagonist, FPL 55712. Prostaglandins. 1983;25:1–11.
Myers RF, Siegel MI. Differential effects of anti-inflammatory drugs on lipoxygenase and cyclooxygenase activities of neutrophils from a reverse passive Arthus reaction. Biochem Biophys Res Commun. 1983;112:586–94.
Boctor AM, Eickholt M, Pugsley TA. Meclofenamate sodium is an inhibitor of both the 5-Lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro. Prostaglandins Leukot Med. 1986;23:229–38.
Harel Z. Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies. Expert Opin Pharmacother. 2012;13(15):2157–70.
Chan WY, Dawood MY, Fuchs F. Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives. Am J Med. 1981;70(3):535–41.
Lindh I, Ellström AA, Milsom I. The effect of combined oral contraceptives and age on dysmenorrhoea: an epidemiological study. Hum Reprod. 2012;27(3):676–82.
Wong CL, Farquhar C, Roberts H, Proctor M. Oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev. 2009;(4):CD002120.
Roumen FJ. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials. Contraception. 2007;75:420–9.
Harada T, Momoeda M. Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2016;106(7):1807–14.
Momoeda M, Kondo M, Elliesen J, Yasuda M, Yamamoto S, Harada T. Efficacy and safety of a flexible extended regimen of ethinylestradiol/drospirenone for the treatment of dysmenorrhea: a multicenter, randomized, open-label, active-controlled study. Int J Womens Health. 2017;9:295–305.
Imai A, Matsunami K, Takagi H, Ichigo S. Levonorgestrel-releasing intrauterine device used for dysmenorrhea: five-year literature review. Clin Exp Obstet Gynecol. 2014;41(5):495–8.
Gold MA, Johnson LM. Intrauterine devices and adolescents. Curr Opin Obstet Gynecol. 2008;20(5):464–9.
Croxatto HB. Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care. 2000;5(Suppl 2):21–8.
Walch K, Unfried G, Huber J, et al. Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis—a pilot study. Contraception. 2009;79:29–34.
Aydar CK, Coleman BD. Treatment of primary dysmenorrhea: a double blind study. JAMA. 1965;192(11):161–3.
Dmitrovic R, Kunselman AR, Legro RS. Sildenafil citrate in the treatment of pain in primary dysmenorrhea: a randomized controlled trial. Hum Reprod. 2013;28:2958–65.
Aktaş D. Prevalence and factors affecting dysmenorrhea in female university students: effect on general comfort level. Pain Manag Nurs. 2015;16(4):534–43.
De Sanctis V, Soliman AT, Elsedfy H, Soliman NA, Soliman R, El Kholy M. Dysmenorrhea in adolescents and young adults: a review in different country. Acta Biomed. 2017;87(3):233–46.
O’Connell K, Davis AR, Westhoff C. Self-treatment patterns among adolescent girls with dysmenorrhea. J Pediatr Adolesc Gynecol. 2006;19:285–9.
Vance AR, Hayes SH, Spielholz NI. Microwave diathermy treatment for primary dysmenorrhea. Phys Ther. 1996;76:1003–8.
Akin MD, Weingand KW, Hengehold DA, Goodale MB, Hinkle RT, Smith RP. Use of continuous low-level topical heat in the treatment of dysmenorrhea. Obstet Gynecol. 2001;97:343–9.
Akin MD, Price W, Rodriguez G Jr, Erasala G, Hurley G, Smith RP. Continuous low-level topical heat wrap therapy compared to acetaminophen for primary dysmenorrhea. J Reprod Med. 2004;49:739–45.
Lee B, Hong SH, Kim K, et al. Efficacy of the device combining high-frequency transcutaneous electrical nerve stimulation and thermotherapy for relieving primary dysmenorrhea: a randomized, single-blind, placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015;194:58–63.
Lundeberg T, Bondesson L, Lundström V. Relief of primary dysmenorrhea by transcutaneous electrical nerve stimulation. Acta Obstet Gynecol Scand. 1985;64(6):491–7.
Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108:428.
Milsom I, Hedner N, Mannheimer CA. Comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea. Am J Obstet Gynecol. 1994;170(1 Pt 1):123–9.
Smith RP, Heltzel J. Interrelation of analgesia and uterine activity in women with primary dysmenorrhea. A preliminary report. J Reprod Med. 1991;36:260–4.
Proctor ML, Smith CA, Farquhar CM, Stones RW. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea (Cochrane review). Cochrane Database Syst Rev. 2002;(1):CD002123.
Wang SF, Lee JP, Hwa HL. Effect of transcutaneous electrical nerve stimulation on primary dysmenorrhea. Neuromodulation. 2009;12(4):302–9.
Kaplan B, Peled Y, Pardo J, et al. Transcutaneous electrical nerve stimulation (TENS) as a relief for dysmenorrhea. Clin Exp Obstet Gynecol. 1994;21(2):87–90.
Dawood MY, Ramos J. Transcutaneous electrical nerve stimulation (TENS) for the treatment of primary dysmenorrhea: a randomized crossover comparison with placebo TENS and ibuprofen. Obstet Gynecol. 1990;75(4):656–60.
Igwea SE, Tabansi-Ochuogu CS, Abaraogu UO. TENS and heat therapy for pain relief and quality of life improvement in individuals with primary dysmenorrhea: a systematic review. Complement Ther Clin Pract. 2016;24:86–91.
Proctor ML, Murphy PA, Pattison HM, et al. Behavioural interventions for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2007;(3):CD002248.
Proctor ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2001;(3):CD002124.
Daily JW, Zhang X, Kim DS, Park S. Efficacy of ginger for alleviating the symptoms of primary dysmenorrhea: A systematic review and meta-analysis of randomized clinical trials. Pain Med. 2015;16(12):2243–55.
Chen CX, Barrett B, Kwekkeboom KL. Efficacy of oral ginger (Zingiber officinale) for dysmenorrhea: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2016;2016:6295737.
Ziaei S, Zakeri M, Kazemnejad A. A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea. BJOG. 2005;112(4):466–9.
Mehrpooya M, Eshraghi A, Rabiee S, Larki-Harchegani A, Ataei S. Comparison of the effect of fish-oil and calcium supplementation on treatment of primary dysmenorrhea. Rev Recent Clin Trials. 2017;12(3):148–53.
Pattanittum P, Kunyanone N, Brown J, et al. Dietary supplements for dysmenorrhoea. Cochrane Database Syst Rev. 2016;(3):CD002124.
Israel RG, Sutton M, O’Brien KF. Effects of aerobic training on primary dysmenorrhea symptomatology in college females. J Am Coll Heal. 1985;33:241–4.
Brown J, Brown S. Exercise for dysmenorrhoea. Cochrane Database Syst Rev. 2010;(2):CD004142.
Golomb LM, Solidum AA, Warren MP. Primary dysmenorrhea and physical activity. Med Sci Sports Exerc. 1998;30:906–9.
Metheny WP, Smith RP. The relationship between exercise, stress, and primary dysmenorrhea. J Behav Med. 1989;12:569–86.
Rakhshaee Z. Effect of three yoga poses (cobra, cat and fish poses) in women with primary dysmenorrhea: a randomized clinical trial. J Pediatr Adolesc Gynecol. 2011;24:192–6.
Yang NY, Kim SD. Effects of a yoga program on menstrual cramps and menstrual distress in undergraduate students with primary dysmenorrhea: a single-blind, randomized controlled trial. J Altern Complement Med. 2016;22(9):732–8.
Hatcher RA. Counseling couples about coitus during menstrual flow. Contracept Technol Update. 1981;2:167.
Juang CM, Yen MS, Twu NF, Horng HC, Yu HC, Chen CY. Impact of pregnancy on primary dysmenorrhea. Int J Gynaecol Obstet. 2006;92(3):221–7.
Barnhart K, Furman I, Devoto L. Attitudes and practice of couples regarding sexual relations during the menses and spotting. Contraception. 1995;51(2):93–8.
Davis AR, Nowygrod S, Shabsigh R, Westhoff C. The influence of vaginal bleeding on the sexual behavior of urban, Hispanic women and men. Contraception. 2002;65(5):351–5.
Daley AJ. Exercise and primary dysmenorrhoea: a comprehensive and critical review of the literature. Sports Med. 2008;38(8):659–70.
Daley AJ. The role of exercise in the treatment of menstrual disorders: the evidence. Br J Gen Pract. 2009;59(561):241–2.
Fisher C, Sibbritt D, Hickman L, Adams JA. Critical review of complementary and alternative medicine use by women with cyclic perimenstrual pain and discomfort: a focus upon prevalence, patterns and applications of use and users’ motivations, information seeking and self-perceived efficacy. Acta Obstet Gynecol Scand. 2016;95:861–71.
Armour M, Smith CA. Treating primary dysmenorrhoea with acupuncture: a narrative review of the relationship between acupuncture ‘dose’ and menstrual pain outcomes. Acupunct Med. 2016;34(6):416–24.
Liu CZ, Xie JP, Wang LP, et al. A randomized controlled trial of single point acupuncture in primary dysmenorrhea. Pain Med. 2014;15(6):910–20.
Smith CA, Armour M, Zhu X, et al. Acupuncture for dysmenorrhoea. Cochrane Database Syst Rev. 2016;(4):CD007854.
Wade C, Wang L, Zhao WJ, et al. Acupuncture point injection treatment of primary dysmenorrhoea: a randomised, double blind, controlled study. BMJ Open. 2016;6(1):e008166.
Yang M, Chen X, Bo L, et al. Moxibustion for pain relief in patients with primary dysmenorrhea: a randomized controlled trial. PLoS One. 2017;12(2):e0170952.
Gao J, Wang Q, Xian S, et al. The effect of moxibustion on alleviating menstrual pain in a population of young nursing students: a prospective randomized cross-over pilot study. Complement Ther Med. 2015;23(6):773–81.
Zhu X, Proctor M, Bensoussan A, et al. Chinese herbal medicine for primary dysmenorrhoea. Cochrane Database Syst Rev. 2007;(2):CD005288.
Pan JC, Tsai YT, Lai JN, Fang RC, Yeh CH. The traditional Chinese medicine prescription pattern of patients with primary dysmenorrhea in Taiwan: a large-scale cross sectional survey. J Ethnopharmacol. 2014;152(2):314–9.
Kokjohn K, Schmid DM, Triano JJ, Brennan PC. The effect of spinal manipulation on pain and prostaglandin levels in women with primary dysmenorrhea. J Manip Physiol Ther. 1992;15(5):279–85.
Proctor ML, Hing W, Johnson TC, Murphy PA. Spinal manipulation for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2006;(3):CD002119.
Hong GY, Shin BC, Park SN, et al. Randomized controlled trial of the efficacy and safety of self-adhesive low-level light therapy in women with primary dysmenorrhea. Int J Gynaecol Obstet. 2016;133(1):37–42.
Uysal M, Doğru HY, Sapmaz E, et al. Investigating the effect of rose essential oil in patients with primary dysmenorrhea. Complement Ther Clin Pract. 2016;24:45–9.
Shah M, Monga A, Patel S, Shah M, Bakshi H. The effect of hypnosis on dysmenorrhea. Int J Clin Exp Hypn. 2014;62(2):164–78.
Additional Resources
American College of Obstetricians and Gynecologists. Noncontraceptive uses of hormonal contraceptives. Practice Bulletin No. 110. Obstet Gynecol. 2010;115:206–18.
Anon. Drugs for pain. Treat Guidel Med Lett. 2013;11(128):31–42.
French L. Dysmenorrhea in adolescents: diagnosis and treatment. Paediatr Drugs. 2008;10(1):1–7.
Burnett M, Lemyre M. No. 345-primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can. 2017;39(7):585–95.
Dawood MY. Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations. Drugs. 1981;22(1):42–56.
Dawood MY. Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea. Am J Med. 1988;84(5A):23–9.
Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108(2):428–41.
Drugs for dysmenorrhea. Med Lett Drugs Ther. 1979;21(20):81–4.
Harel Z. Dysmenorrhea in adolescents. Ann N Y Acad Sci. 2008;1135:185–95.
Lefebvre G, Pinsonneault O, Antao V, et al. Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can. 2005;27(12):1117–46.
Latthe PM, Champaneria R, Khan KS. Dysmenorrhoea. BMJ Clin Evid. 2011;2011. pii: 0813.
Marjoribanks J, Proctor M, Farquhar C, Derks RS. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2010;(7):CD001751.
Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ Clin Evid. 2007;2007. pii: 0813.
Ryan SA. The treatment of dysmenorrhea. Pediatr Clin N Am. 2017;64(2):331–42.
Sanfilippo J, Erb T. Evaluation and management of dysmenorrhea in adolescents. Clin Obstet Gynecol. 2008;51(2):257–67.
For a quick and general overview of many of the pathologies that cause secondary dysmenorrhea:
Smith RP. Netter’s obstetrics & gynecology. 3rd ed. Philadelphia: Elsevier; 2017. p. 71–3.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Smith, R.P. (2018). Management Strategies for Primary Dysmenorrhea. In: Dysmenorrhea and Menorrhagia. Springer, Cham. https://doi.org/10.1007/978-3-319-71964-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-71964-1_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-71963-4
Online ISBN: 978-3-319-71964-1
eBook Packages: MedicineMedicine (R0)